CN106039036A - 一种抗衰老的中药组合物 - Google Patents
一种抗衰老的中药组合物 Download PDFInfo
- Publication number
- CN106039036A CN106039036A CN201610644712.6A CN201610644712A CN106039036A CN 106039036 A CN106039036 A CN 106039036A CN 201610644712 A CN201610644712 A CN 201610644712A CN 106039036 A CN106039036 A CN 106039036A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- herba
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 230000003712 anti-aging effect Effects 0.000 title abstract description 3
- 239000000284 extract Substances 0.000 claims abstract description 21
- 241000005787 Cistanche Species 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 241000222336 Ganoderma Species 0.000 claims description 15
- 241000124755 Anthriscus Species 0.000 claims description 13
- 241000208340 Araliaceae Species 0.000 claims description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 12
- 235000008434 ginseng Nutrition 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000009835 boiling Methods 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 244000236658 Paeonia lactiflora Species 0.000 claims description 4
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims description 4
- 239000011812 mixed powder Substances 0.000 claims description 4
- 210000004709 eyebrow Anatomy 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 235000013372 meat Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 230000006870 function Effects 0.000 abstract description 9
- 230000032683 aging Effects 0.000 abstract description 6
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 230000003020 moisturizing effect Effects 0.000 abstract description 3
- 239000000047 product Substances 0.000 abstract description 3
- 239000003053 toxin Substances 0.000 abstract description 3
- 231100000765 toxin Toxicity 0.000 abstract description 3
- 230000002035 prolonged effect Effects 0.000 abstract 2
- 240000007772 Anthriscus sylvestris Species 0.000 abstract 1
- 235000005749 Anthriscus sylvestris Nutrition 0.000 abstract 1
- 241000026010 Dendrobium candidum Species 0.000 abstract 1
- 244000286838 Eclipta prostrata Species 0.000 abstract 1
- 240000008397 Ganoderma lucidum Species 0.000 abstract 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 1
- 241000414067 Inonotus obliquus Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 235000002789 Panax ginseng Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 108700012359 toxins Proteins 0.000 abstract 1
- 235000020334 white tea Nutrition 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 16
- 210000003734 kidney Anatomy 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 6
- 238000007689 inspection Methods 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000003796 beauty Effects 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 4
- -1 hydroxyl radical free radical Chemical class 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 201000004384 Alopecia Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010024419 Libido decreased Diseases 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 231100000460 acute oral toxicity Toxicity 0.000 description 3
- 239000007844 bleaching agent Substances 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000003676 hair loss Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 241001222569 Betula minor Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 206010029446 nocturia Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000233788 Arecaceae Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001313086 Betula platyphylla Species 0.000 description 1
- 235000001553 Betula platyphylla Nutrition 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical class CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- YTJJRAWFHJBAMT-UHFFFAOYSA-N depside Natural products OC(=O)CC1=C(O)C=C(O)C=C1OC(=O)C1=CC=C(O)C(O)=C1 YTJJRAWFHJBAMT-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000011318 facial edema Diseases 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000008738 huangbai Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 1
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种抗衰老的中药组合物,由灵芝、红参、绞股蓝、枸杞子、黄糖、肉苁蓉、铁皮石斛、白桦茸、白茶提取物、墨旱莲和峨参叶组成。本发明的中药原料合理配伍,相辅相成,协同作用,能消除人体内的自由基和毒素,重建和保护细胞基础结构,延长传代细胞的分裂代数,增进细胞寿命,维护细胞的正常功能并促进新陈代谢,具有延缓衰老、还原肌肤保湿、肤色和弹性的美容功效,能从根本上起到抗衰老的疗效,总有效率高达98~100%,并且无毒副作用,安全可靠,不反弹。
Description
技术领域
本发明属于中药领域,具体涉及一种抗衰老的中药组合物。
背景技术
衰老一般是指当机体发育较为成熟之后,各项功能活动慢慢减退,呈现一个整体下降趋势,这是一种非常复杂的生命现象。在现阶段,随着经济的发展和生活水平的提高,人们对抗衰老、美容驻颜越来越重视,人们对生命质量关注度越来越高,而如何有效抗衰老也已经成了目前社会各界所探讨的问题。因为西药造成的不良反应比较多,而老年的患者如法承受太多的不良反应,所以中药显著的疗效受到了抗衰老研究的重视。
发明内容
本发明的目的在于针对现有技术不足,提供一种抗衰老的中药组合物。本发明的中药组合物具有延缓衰老、还原肌肤保湿、肤色和弹性的美容功效,能从根本上起到抗衰老的疗效,总有效率高达98~100%,并且无毒副作用,安全可靠,不反弹。
为实现上述目的,本发明采用如下技术方案:
一种抗衰老的中药组合物,是由以下重量份数的原料组成:灵芝200~220份、红参100~120份、绞股蓝90~110份、枸杞子90~110份、黄糖180~220份、肉苁蓉60~80份、铁皮石斛80~100份、白桦茸40~60份、白茶提取物20~30份、墨旱莲30~50份和峨参叶30~50份。
优选的,一种抗衰老的中药组合物,是由以下重量份数的原料组成:灵芝200份、红参100份、绞股蓝100份、枸杞子100份、黄糖200份、肉苁蓉70份、铁皮石斛90份、白桦茸50份、白茶提取物25份、墨旱莲40份和峨参叶40份。
所述的白茶提取物为白牡丹提取物、寿眉提取物和白毫银针提取物中的任一种。
本发明中各中药的药理作用如下:
灵芝:味甘性平,入心经,能补心血、益心气、安心神,故可用治气血不足、心神失养所致的心神不宁、失眠、惊悸、多梦、健忘、体倦神疲、食少等症;灵芝中的灵芝多糖GLA、GLB、GLC对超氧阴离子(O)自由基的产生和红细胞脂质过氧化均有抑制作用,并对羟基自由基(·OH)有清除作用,具有超氧化物歧化酶样活性,是灵芝延缓衰老的重要因素。
红参:甘、微苦,温。归经:归脾、肺、心经。功效与主治:大补元气,复脉固脱,益气摄血。用于体虚欲脱,肢冷脉微,气不摄血,崩漏下血;心力衰竭,心原性休克。
绞股蓝:味甘、苦,性微寒。归肺经、脾经、肾经。能益气,安神,降血压,清热解毒,止咳祛痰。
枸杞子:甘,平。归肝、肾经。滋补肝肾、精益明目,用于虚劳精亏,腰膝酸痛,眩晕耳鸣,阳痿遗精,内热消渴,血虚萎黄,目昏不明。
黄糖:健脾益气,缓肝补血、活血祛瘀,止痛的功效;红糖中含有的多种维他命和抗氧化物质,能抵抗自由基,重建和保护细胞基础结构,维护细胞的正常功能和新陈代谢;有活血美容的功效。
肉苁蓉:性味:甘、咸,温。归肾、大肠经。功效与主治:补肾助阳,润肠通便。
铁皮石斛:性味:味甘,性微寒。归胃、肾经。功效与主治:生津养胃;滋阴清热;润肺益肾;明目强腰。
白桦茸:化学成分有三萜类化合物、多糖类化合物、木质素类、鞘氨脂类似物、白桦脂酸、甘露醇、SOD( 超氧化物歧化酶 )、栓菌酸、生物碱、香草酸、熊果酸、半单宁化合物、丁香酸和 Y- 羟基苯甲酸等成分。能清除体内自由基和毒素,保护细胞,延长传代细胞的分裂代数,增进细胞寿命,促进代谢,调节荷尔蒙正常分泌,提高内源性雌激素分泌,改善睡眠、润肠通便、分解脂肪、降低胆固醇储量、缓解焦虑、抑郁的功效,具有延缓衰老、还原肌肤保湿、肤色和弹性的美容功效。
白茶提取物:主要成分有茶素类(黄烷醇类)、酚酸、黄酮醇类、缩酚酸类等,具有治麻疹、明目、抗癌、抗肿瘤、抗突变、抗菌、抗氧化,抗辐射、降低血糖、护肝保肝、消除疲劳、减肥、调节免疫功能等药理活性。
墨旱莲:性味:甘、酸,寒。归经:归肾、肝经。功能主治:滋补肝肾,凉血止血。用于牙齿松动,须发早白,眩晕耳鸣,腰膝酸软,阴虚血热、吐血、衄血、尿血,血痢,崩漏下血,外伤出血。
峨参叶:味甘,辛,性平。具有美容、驻颜的功效。、
如上所述的抗衰老的中药组合物的制备方法,具体包括以下步骤:
(1)将灵芝、红参、绞股蓝、枸杞子、肉苁蓉、铁皮石斛、白桦茸、墨旱莲和峨参叶混合后,用8倍重量的沸水煎煮30分钟后,过滤并收集滤液,并将所得滤渣用6倍重量的沸水再煎煮30分钟后,过滤并收集滤液,合并两次提取液;
(2)在步骤(1)所得提取液中加入白茶提取物和黄糖后,在70~80℃下浓缩得浸膏,随后流通蒸汽灭菌30min,蒸汽温度为121℃,蒸汽压力0.11Mpa;将所得浸膏喷雾干燥得混合粉末,制得所述中药组合物,所述浸膏密度为1.0g/cm3。
本发明的有益效果在于:本发明的中药原料合理配伍,相辅相成,协同作用,能消除人体内的自由基和毒素,重建和保护细胞基础结构,延长传代细胞的分裂代数,增进细胞寿命,维护细胞的正常功能并促进新陈代谢,具有延缓衰老、还原肌肤保湿、肤色和弹性的美容功效,能从根本上起到抗衰老的疗效,总有效率高达98~100%,并且无毒副作用,安全可靠,不反弹。
具体实施方式
以下结合具体实施例对本发明做进一步说明,但本发明不仅仅限于这些实施例。
实施例1
一种抗衰老的中药组合物,是由以下重量份数的原料组成:灵芝210份、红参110份、绞股蓝90份、枸杞子90份、黄糖180份、肉苁蓉60份、铁皮石斛80份、白桦茸40份、白牡丹提取物20份、墨旱莲30份和峨参叶30份。
如上所述的抗衰老的中药组合物的制备方法,具体包括以下步骤:
(1)将灵芝、红参、绞股蓝、枸杞子、肉苁蓉、铁皮石斛、白桦茸、墨旱莲和峨参叶混合后,用8倍重量的沸水煎煮30分钟后,过滤并收集滤液,并将所得滤渣用6倍重量的沸水再煎煮30分钟后,过滤并收集滤液,合并两次提取液;
(2)在步骤(1)所得提取液中加入白牡丹提取物和黄糖后,在70℃下浓缩得浸膏,随后流通蒸汽灭菌30min,蒸汽温度为121℃,蒸汽压力0.11Mpa;将所得浸膏喷雾干燥得混合粉末,制得所述中药组合物,所述浸膏密度为1.0g/cm3。
实施例2
一种抗衰老的中药组合物,是由以下重量份数的原料组成:灵芝220份、红参120份、绞股蓝110份、枸杞子110份、黄糖220份、肉苁蓉80份、铁皮石斛100份、白桦茸60份、寿眉提取物30份、墨旱莲50份和峨参叶50份。
如上所述的抗衰老的中药组合物的制备方法,具体包括以下步骤:
(1)将灵芝、红参、绞股蓝、枸杞子、肉苁蓉、铁皮石斛、白桦茸、墨旱莲和峨参叶混合后,用8倍重量的沸水煎煮30分钟后,过滤并收集滤液,并将所得滤渣用6倍重量的沸水再煎煮30分钟后,过滤并收集滤液,合并两次提取液;
(2)在步骤(1)所得提取液中加入寿眉提取物和黄糖后,在80℃下浓缩得浸膏,随后流通蒸汽灭菌30min,蒸汽温度为121℃,蒸汽压力0.11Mpa;将所得浸膏喷雾干燥得混合粉末,制得所述中药组合物,所述浸膏密度为1.0g/cm3。
实施例3
一种抗衰老的中药组合物,是由以下重量份数的原料组成:灵芝200份、红参100份、绞股蓝100份、枸杞子100份、黄糖200份、肉苁蓉70份、铁皮石斛90份、白桦茸50份、白毫银针提取物25份、墨旱莲40份和峨参叶40份。
如上所述的抗衰老的中药组合物的制备方法,具体包括以下步骤:
(1)将灵芝、红参、绞股蓝、枸杞子、肉苁蓉、铁皮石斛、白桦茸、墨旱莲和峨参叶混合后,用8倍重量的沸水煎煮30分钟后,过滤并收集滤液,并将所得滤渣用6倍重量的沸水再煎煮30分钟后,过滤并收集滤液,合并两次提取液;
(2)在步骤(1)所得提取液中加入白毫银针提取物和黄糖后,在75℃下浓缩得浸膏,随后流通蒸汽灭菌30min,蒸汽温度为121℃,蒸汽压力0.11Mpa;将所得浸膏喷雾干燥得混合粉末,制得所述中药组合物,所述浸膏密度为1.0g/cm3。
一、药物毒性实验
急性经口毒性试验:该品按卫生部《化妆品卫生规范》 (2002年版 )“急性经口毒性试验中一次限量试验法”,一次经口给予小白鼠(体重18g~22g),20只,将本发明的中药组合物用蒸馏水溶解,获得灌胃量20ml/kg,经口给予20只小白鼠,观察 15 天,试验动物未发现中毒表现、无死亡,处死后解剖未明显异常,判断该品对小鼠急性经口毒性属实际无毒级。
二、临床试验
1. 临床资料:在某省级医院招募100例患者,均符合国家卫生部1993年颁发的《抗衰老药物临床研究指导原则》的实行标准。其中男50名,女50名,患者年龄在45-60岁之间,平均年龄51岁。
2. 治疗方法:服用本发明药物,每天服药1次,15天为1个疗程,共服用2个疗程。
3. 评分标准:参照国家卫生部1993年颁发的《抗衰老药物临床研究指导原则》实行标准,具体如下:
①肾气虚:
望诊、脉诊:面色黄白;舌淡胖、苔白;脉细弱。
问诊:a. 主要症状:腰膝酸软;疲倦乏力;b. 次要症状:夜尿频;自汗、气短;耳鸣;发脱或变白;健忘、齿摇;性欲减退。
②肾阴虚:
望诊、脉诊:两颧潮红;舌红少苔;脉细数。
问诊:a. 主要症状:腰膝酸软;五心烦热;b. 次要症状:头晕耳鸣;盗汗;口舌干燥;便秘;发脱或变白;健忘、齿摇;性欲减退。
③肾阳虚:
望诊、脉诊:面目虚浮;舌淡胖而润、苔白厚;脉沉细,两尺脉弱。
问诊:a. 主要症状:腰膝酸软;畏寒肢冷;次要症状:夜尿频;精神不振;气短而喘;大便溏薄;发脱或变白;健忘、齿摇;性欲减退。
1)问诊:用统一的语句提问,凡主动说出的症状记4分;问出的症状按照症状显著或持续出现记为3分,症状时轻时重或间断出现记为2分,症状轻或偶尔出现1分,无症状为0分。
2)望诊和脉诊:望诊和脉诊中具有任意一条记为6分。
3)各型肾虚应必备主要症状2项,次要症状中任意3项和望诊、脉诊中的1项,或积分≥13分。
4. 疗效评定标准:
显效:治疗后衰老症状积分与治疗前相比下降2/3或 2/3以上。
有效:治疗后衰老症状积分与治疗前相比下降1/3 ~ 2/3。
无效:治疗后衰老症状积分与治疗前相比下降1/3 以下。
5.治疗结果:
服用本发明实施例1~3的药物后,2个疗程后,临床试验100例患者的治疗效果如表1所示。
表1 抗衰老的治疗效果
以上所述仅为本发明的较佳实施例,凡依本发明申请专利范围所做的均等变化与修饰,皆应属本发明的涵盖范围。
Claims (4)
1.一种抗衰老的中药组合物,其特征在于:所述中药组合物是由以下重量份数的原料组成:灵芝200~220份、红参100~120份、绞股蓝90~110份、枸杞子90~110份、黄糖180~220份、肉苁蓉60~80份、铁皮石斛80~100份、白桦茸40~60份、白茶提取物20~30份、墨旱莲30~50份和峨参叶30~50份。
2.根据权利要求1所述的抗衰老的中药组合物,其特征在于:所述中药组合物是由以下重量份数的原料组成:灵芝200份、红参100份、绞股蓝100份、枸杞子100份、黄糖200份、肉苁蓉70份、铁皮石斛90份、白桦茸50份、白茶提取物25份、墨旱莲40份和峨参叶40份。
3.根据权利要求1或2所述的抗衰老的中药组合物,其特征在于:所述的白茶提取物为白牡丹提取物、寿眉提取物和白毫银针提取物中的任一种。
4.一种制备如权利要求1-3中任一项所述的抗衰老的中药组合物的方法,其特征在于:具体包括以下步骤:
(1)将灵芝、红参、绞股蓝、枸杞子、肉苁蓉、铁皮石斛、白桦茸、墨旱莲和峨参叶混合后,用8倍重量的沸水煎煮30分钟后,过滤并收集滤液,并将所得滤渣用6倍重量的沸水再煎煮30分钟后,过滤并收集滤液,合并两次提取液;
(2)在步骤(1)所得提取液中加入白茶提取物和黄糖后,在70~80℃下浓缩得浸膏,随后流通蒸汽灭菌30min,蒸汽温度为121℃,蒸汽压力0.11Mpa;将所得浸膏喷雾干燥得混合粉末,制得所述中药组合物,所述浸膏密度为1.0g/cm3。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610644712.6A CN106039036A (zh) | 2016-08-09 | 2016-08-09 | 一种抗衰老的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610644712.6A CN106039036A (zh) | 2016-08-09 | 2016-08-09 | 一种抗衰老的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106039036A true CN106039036A (zh) | 2016-10-26 |
Family
ID=57480856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610644712.6A Pending CN106039036A (zh) | 2016-08-09 | 2016-08-09 | 一种抗衰老的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106039036A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107638516A (zh) * | 2017-11-08 | 2018-01-30 | 广州市络捷生物科技有限公司 | 一种减缓皮肤衰老中药组合物及其制备方法 |
CN114929195A (zh) * | 2020-01-02 | 2022-08-19 | 株式会社Lg生活健康 | 含有植物提取物的组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103463458A (zh) * | 2013-09-26 | 2013-12-25 | 张娥珍 | 铁皮石斛复配咀嚼片及其制备方法 |
CN104666618A (zh) * | 2013-12-03 | 2015-06-03 | 天津尖峰弗兰德医药科技发展有限公司 | 一种具有抗衰老作用的中药组合物 |
-
2016
- 2016-08-09 CN CN201610644712.6A patent/CN106039036A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103463458A (zh) * | 2013-09-26 | 2013-12-25 | 张娥珍 | 铁皮石斛复配咀嚼片及其制备方法 |
CN104666618A (zh) * | 2013-12-03 | 2015-06-03 | 天津尖峰弗兰德医药科技发展有限公司 | 一种具有抗衰老作用的中药组合物 |
Non-Patent Citations (1)
Title |
---|
陈敏章: "《中华内科学》", 31 October 1999 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107638516A (zh) * | 2017-11-08 | 2018-01-30 | 广州市络捷生物科技有限公司 | 一种减缓皮肤衰老中药组合物及其制备方法 |
CN107638516B (zh) * | 2017-11-08 | 2021-05-11 | 广州市络捷生物科技有限公司 | 一种减缓皮肤衰老中药组合物及其制备方法 |
CN114929195A (zh) * | 2020-01-02 | 2022-08-19 | 株式会社Lg生活健康 | 含有植物提取物的组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101485830B (zh) | 一种中药抗衰老保健胶囊 | |
CN105543052A (zh) | 一种养生补肾黄秋葵酒及其制备方法 | |
CN104083740A (zh) | 一种用于增肥的内服中药 | |
CN101518595A (zh) | 具有降脂减肥、抗氧化功能的药物组合物及其制备方法 | |
CN106039036A (zh) | 一种抗衰老的中药组合物 | |
CN102715322A (zh) | 一种食品养颜茶冲剂 | |
CN102640826B (zh) | 一种改善营养性贫血的食品养血茶冲剂 | |
CN102640920B (zh) | 一种食品美容茶冲剂 | |
CN106360194A (zh) | 一种枸杞植物饮料及其制备方法 | |
CN102344880A (zh) | 一种保健酒及其生产方法 | |
CN104001162A (zh) | 一种治疗心脏神经症的药剂及其制备方法 | |
CN108835615A (zh) | 一种用于辅助降血压的组合物 | |
CN102669340A (zh) | 一种改善营养性贫血的食品养血茶冲剂 | |
CN103461590A (zh) | 一种改善营养性贫血的食品养血茶冲剂 | |
CN103301341A (zh) | 一种治疗缺血性脑中风的中药组合物 | |
CN112402569A (zh) | 一种抗疲劳保健品及其制备方法 | |
CN112316051A (zh) | 养血化痰中药组合物及其中药制剂、制备方法和应用 | |
CN104800600A (zh) | 一种治疗高血压的药物 | |
CN104857121A (zh) | 一种治疗高血脂症的药物组合物及其应用 | |
CN109364113A (zh) | 一种白藜芦醇和中药提取物的组合物和用途 | |
CN109223855A (zh) | 一种富含维生素e中药提取物组合物和用途 | |
CN108853340A (zh) | 一种滋养肝肾的中药及其制备方法 | |
CN108714176A (zh) | 一种治疗头发花白的中药 | |
CN108378308A (zh) | 一种鹿血双色片保健食品及其制备方法 | |
CN106039270A (zh) | 一种治疗老年痴呆症的中药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161026 |
|
RJ01 | Rejection of invention patent application after publication |